Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Benlysta (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-5 of 5
» View wsbt.com items only
    Jul 16, 2012 |Story| Baltimore Sun

  1. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Mergers, Acquisitions and Takeovers, AstraZeneca Plc, Bristol Myers Squibb Company, Companies and Corporations, Diseases and Illnesses

    2. Jun 8, 2012 |Story| Baltimore Sun

  2. Ripley's opens Odditorium at Harborplace

    Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...

    Tags: Harborplace, Companies and Corporations, Science and Technology, Inner Harbor, Bankruptcy

    3. May 9, 2012 |Story| Los Angeles Times

  3. Glaxo's fight for Human Genome Sciences gets nasty

    British pharmaceutical giant GlaxoSmithKline is dropping the cordial overtures toward its takeover target and occasional business partner Human Genome Sciences Inc.
    British pharmaceutical giant GlaxoSmithKline is dropping the cordial overtures toward its takeover target and occasional business partner Human Genome Sciences Inc. Instead, Glaxo plans to launch a hostile $2.6-billion tender offer this week, putting its...

    Tags: Science, Companies and Corporations, Science and Technology, London Theatre, Google+

    4. Apr 21, 2012 |Story| Baltimore Sun

  4. Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...

    Tags: AstraZeneca Plc, Mergers, Acquisitions and Takeovers, Montgomery County (Maryland), Restructuring and Recapitalization, Healthcare Provider

    5. Apr 19, 2012 |Story| Baltimore Sun

  5. Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline

    Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...

    Tags: Science, Stock Market, Cancer, Companies and Corporations, Science and Technology

Original site for Benlysta (drug) topic gallery.